Interestingly, the EGR-1 signaling axis is closely tied to the production of VEGF, providing a potential molecular link between BPC-157, early gene response, and the previously observed pro-angiogenic effects
It also reduces inflammation, speeds up recovery time, and helps prevent muscle atrophy
Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS
Some patients report changes in comfort, mobility, or recovery within the first few weeks, but results vary and should not replace diagnosis, imaging, rehab, or medical treatment